{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:23:58Z","timestamp":1795148638011,"version":"4.10.3"},"reference-count":47,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among the recently described subtypes in childhood B-lymphoblastic leukemia (B-ALL) were DUX4- and PAX5-altered (PAX5alt). By using whole transcriptome RNA sequencing in 377 children with B-ALL from the Malaysia-Singapore ALL 2003 (MS2003) and Malaysia-Singapore ALL 2010 (MS2010) studies, we found that, after hyperdiploid and ETV6-RUNX1, the third and fourth most common subtypes were DUX4 (n = 51; 14%) and PAX5alt (n = 36; 10%). DUX4 also formed the largest genetic subtype among patients with poor day-33 minimal residual disease (MRD; n = 12 of 44). But despite the poor MRD, outcome of DUX4 B-ALL was excellent (5-year cumulative risk of relapse [CIR], 8.9%; 95% confidence interval [CI], 2.8%-19.5% and 5-year overall survival, 97.8%; 95% CI, 85.3%-99.7%). In MS2003, 21% of patients with DUX4 B-ALL had poor peripheral blood response to prednisolone at day 8, higher than other subtypes (8%; P = .03). In MS2010, with vincristine at day 1, no day-8 poor peripheral blood response was observed in the DUX4 subtype (P = .03). The PAX5alt group had an intermediate risk of relapse (5-year CIR, 18.1%) but when IKZF1 was not deleted, outcome was excellent with no relapse among 23 patients. Compared with MS2003, outcome of PAX5alt B-ALL with IKZF1 codeletion was improved by treatment intensification in MS2010 (5-year CIR, 80.0% vs 0%; P = .05). In conclusion, despite its poor initial response, DUX4 B-ALL had a favorable overall outcome, and the prognosis of PAX5alt was strongly dependent on IKZF1 codeletion.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004895","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T23:59:21Z","timestamp":1632268761000},"page":"5226-5238","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":53,"title":["Distinct clinical characteristics of<i>DUX4-<\/i>and<i>PAX5<\/i>-altered childhood B-lymphoblastic leukemia"],"prefix":"10.1182","volume":"5","author":[{"given":"Zhenhua","family":"Li","sequence":"first","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn Hsien Ren","family":"Lee","sequence":"additional","affiliation":[{"name":"Viva-University Children\u2019s Cancer Centre, Khoo Teck Puat-National University Children\u2019s Medical Institute, National University Hospital, National University Health System, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie Hui Ni","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Huizi","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Coustan-Smith","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kean Hui","family":"Chiew","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-8935","authenticated-orcid":false,"given":"Bernice Ling Zhi","family":"Oh","sequence":"additional","affiliation":[{"name":"Viva-University Children\u2019s Cancer Centre, Khoo Teck Puat-National University Children\u2019s Medical Institute, National University Hospital, National University Health System, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Shimin","family":"Koh","sequence":"additional","affiliation":[{"name":"Dean\u2019s Office, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Kow Yin","family":"Kham","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan Chong","family":"Quah","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"},{"name":"Viva-University Children\u2019s Cancer Centre, Khoo Teck Puat-National University Children\u2019s Medical Institute, National University Hospital, National University Health System, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Peng","family":"Lin","sequence":"additional","affiliation":[{"name":"Subang Jaya Medical Centre, Subang Jaya, Malaysia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-3675","authenticated-orcid":false,"given":"Ah Moy","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Kandang Kerbau Women\u2019s and Children\u2019s Hospital, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Ariffin","sequence":"additional","affiliation":[{"name":"University of Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-976X","authenticated-orcid":false,"given":"Allen Eng-Juh","family":"Yeoh","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, VIVA-NUS Centre for Translational Research in Acute Leukaemia , Yong Loo Lin School of Medicine, National University of Singapore, Singapore;"},{"name":"Viva-University Children\u2019s Cancer Centre, Khoo Teck Puat-National University Children\u2019s Medical Institute, National University Hospital, National University Health System, Singapore;"},{"name":"Cancer Science Institute of Singapore, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"11","key":"2021120716261014900_B1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica."},{"issue":"2","key":"2021120716261014900_B2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell."},{"issue":"1","key":"2021120716261014900_B3","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebj\u00f6rn","year":"2016","journal-title":"Nat Commun."},{"issue":"5","key":"2021120716261014900_B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat Genet."},{"issue":"12","key":"2021120716261014900_B5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet."},{"issue":"8","key":"2021120716261014900_B6","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41375-019-0430-z","article-title":"PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia","volume":"33","author":"Bastian","year":"2019","journal-title":"Leukemia."},{"issue":"2","key":"2021120716261014900_B7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet."},{"issue":"50","key":"2021120716261014900_B8","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2021120716261014900_B9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J Clin Oncol."},{"issue":"19","key":"2021120716261014900_B10","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1200\/JCO.2011.40.5936","article-title":"Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study","volume":"30","author":"Yeoh","year":"2012","journal-title":"J Clin Oncol."},{"issue":"26","key":"2021120716261014900_B11","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1200\/JCO.2018.78.3050","article-title":"Intensifying treatment of childhood B-lymphoblastic leukemia with IKZF1 deletion reduces relapse and improves overall survival: Results of Malaysia-Singapore ALL 2010 Study","volume":"36","author":"Yeoh","year":"2018","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021120716261014900_B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia."},{"issue":"4","key":"2021120716261014900_B13","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"issue":"7","key":"2021120716261014900_B14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics."},{"issue":"12","key":"2021120716261014900_B15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"6","key":"2021120716261014900_B16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics."},{"issue":"3","key":"2021120716261014900_B17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","article-title":"Rank transformations as a bridge between parametric and nonparametric statistics","volume":"35","author":"Conover","year":"1981","journal-title":"Am Statistician."},{"issue":"2","key":"2021120716261014900_B18","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Statist."},{"issue":"3","key":"2021120716261014900_B19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: Which algorithms implement Ward\u2019s criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J Classif."},{"key":"2021120716261014900_B20","article-title":"FusionCatcher - a tool for finding somatic fusion genes in paired-end RNA-sequencing data","author":"Nicorici","year":"2014","journal-title":"bioRxiv."},{"issue":"1110","key":"2021120716261014900_B21","first-page":"11.10.1","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics."},{"issue":"1","key":"2021120716261014900_B22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"2021120716261014900_B23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"issue":"3","key":"2021120716261014900_B24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist."},{"issue":"3","key":"2021120716261014900_B25","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep."},{"issue":"446","key":"2021120716261014900_B26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"issue":"2","key":"2021120716261014900_B27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B."},{"issue":"3","key":"2021120716261014900_B28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.2020006164","article-title":"Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia","volume":"137","author":"Nishii","year":"2021","journal-title":"Blood."},{"issue":"7","key":"2021120716261014900_B29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica."},{"issue":"1","key":"2021120716261014900_B30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/leu.2013.277","article-title":"An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions","volume":"28","author":"Clappier","year":"2014","journal-title":"Leukemia."},{"issue":"23","key":"2021120716261014900_B31","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood."},{"issue":"2","key":"2021120716261014900_B32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol."},{"issue":"26","key":"2021120716261014900_B33","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood."},{"issue":"10","key":"2021120716261014900_B34","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2012.101","article-title":"Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia","volume":"26","author":"Palmi","year":"2012","journal-title":"Leukemia."},{"key":"2021120716261014900_B35","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun."},{"key":"2021120716261014900_B36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine."},{"issue":"28","key":"2021120716261014900_B37","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2016.66.5547","article-title":"MEF2D-BCL9 fusion gene is associated with high-risk acute B-cell precursor lymphoblastic leukemia in adolescents","volume":"34","author":"Suzuki","year":"2016","journal-title":"J Clin Oncol."},{"issue":"1","key":"2021120716261014900_B38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.2017.186320","article-title":"Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion","volume":"104","author":"Ohki","year":"2019","journal-title":"Haematologica."},{"key":"2021120716261014900_B39","first-page":"563291","article-title":"t(17;19) in children with acute lymphocytic leukemia: A report of 3 cases and a review of the literature","volume":"2013","author":"Minson","year":"2013","journal-title":"Case Rep Hematol."},{"issue":"9","key":"2021120716261014900_B40","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet."},{"issue":"2","key":"2021120716261014900_B41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia."},{"key":"2021120716261014900_B42","article-title":"Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group [published online ahead of print on 10 March 2021]","author":"Hirabayashi","journal-title":"Leukemia."},{"issue":"8","key":"2021120716261014900_B43","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3324\/haematol.2020.250423","article-title":"DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch","volume":"106","author":"Novakova","year":"2021","journal-title":"Haematologica."},{"issue":"4","key":"2021120716261014900_B44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"27","key":"2021120716261014900_B45","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol."},{"issue":"7","key":"2021120716261014900_B46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41375-021-01185-6","article-title":"Role of transcriptome sequencing in clinical diagnosis of B-cell acute lymphoblastic leukemia","volume":"35","author":"Li","year":"2021","journal-title":"Leukemia."},{"issue":"9","key":"2021120716261014900_B47","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/s41375-020-0774-4","article-title":"Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/23\/5226\/1849685\/advancesadv2021004895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/23\/5226\/1849685\/advancesadv2021004895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T17:39:50Z","timestamp":1725817190000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/23\/5226\/476982\/Distinct-clinical-characteristics-of-DUX4-and-PAX5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":47,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004895","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}